NCT05790889View on ClinicalTrials.gov

A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

April 3, 2023

Primary Completion Date

May 30, 2026

Study Completion Date

May 30, 2026

Conditions
Malaria,Falciparum
Interventions
BIOLOGICAL

Rabies vaccine

Vaccine

BIOLOGICAL

RH5.1 10μg adjuvated with 50μg Matrix-M

Vaccine

BIOLOGICAL

RH5.2 5μg adjuvated with 50μg Matrix-M

Vaccine

Trial Locations (1)

BP 7192 OUAGADOUGOU 03, BF

RECRUITING

Institut de Recherche en Sciences de la Santé, Siglé

All Listed Sponsors
collaborator

Institut de Recherche en Sciences de la Sante, Burkina Faso

OTHER_GOV

collaborator

European and Developing Countries Clinical Trials Partnership (EDCTP)

OTHER_GOV

collaborator

Wellcome Trust

OTHER

lead

University of Oxford

OTHER